Five weeks of nanoparticle treatment reduced artery damage by up to 80% in mice
Very promising core-shell nanoparticle platform employs a hydrophobic interior comprising PLGA, a block copolymer of lactic and glycolic acids—both natural metabolic products—and diagnostic and therapeutic cargo molecules. Some PLGA molecules are linked to a fluorescent dye to track the disposition of the nanoparticles in animals. Encapsulated with the PLGA are molecules of a 25-amino acid …